Neurotransmitter and neuropeptide mechanisms responsible for the development of a withdrawal syndrome in morphine-dependent animals View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1999-03

AUTHORS

L. A. Gromov, M. A. Filonenko

ABSTRACT

The neurotransmitter and neuropeptide mechanisms responsible for the development of the morphine drug dependence and a withdrawal syndrome (WS) were studied in rats. Physical dependence and WS were found to develop against the background of restricted responsiveness of the adrenergic and dopaminergic systems. At the same time, the activity of the serotonin-, GABA-, vasopressin-, and oxytocinergic systems is suppressed at the WS. Agonists of opiate receptors, butorphanol and loperamid, were shown to improve the physical state of the animals with a WS. Similar action was found to be exerted by activators of the adrenergic system (ephedrine, phenylephrine), dopaminergic system (levoDOPA, apomorphine), and serotonergic system (tryptophan), as well as by neuropeptides, vasopressin and oxytocin. More... »

PAGES

115-120

References to SciGraph publications

  • 1998-02. Changes of α-B-crystalline in cardiac grafts in BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1007/bf02515049

    DOI

    http://dx.doi.org/10.1007/bf02515049

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1008621160


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1115", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Pharmacology and Pharmaceutical Sciences", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Institute of Pharmacology and Toxicology, Academy of Medical Sciences of Ukraine, Kyiv, Ukraine", 
              "id": "http://www.grid.ac/institutes/grid.419973.1", 
              "name": [
                "Institute of Pharmacology and Toxicology, Academy of Medical Sciences of Ukraine, Kyiv, Ukraine"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Gromov", 
            "givenName": "L. A.", 
            "id": "sg:person.01101343454.71", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01101343454.71"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Institute of Pharmacology and Toxicology, Academy of Medical Sciences of Ukraine, Kyiv, Ukraine", 
              "id": "http://www.grid.ac/institutes/grid.419973.1", 
              "name": [
                "Institute of Pharmacology and Toxicology, Academy of Medical Sciences of Ukraine, Kyiv, Ukraine"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Filonenko", 
            "givenName": "M. A.", 
            "id": "sg:person.01005415734.94", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01005415734.94"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1007/bf02496848", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1003276335", 
              "https://doi.org/10.1007/bf02496848"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "1999-03", 
        "datePublishedReg": "1999-03-01", 
        "description": "The neurotransmitter and neuropeptide mechanisms responsible for the development of the morphine drug dependence and a withdrawal syndrome (WS) were studied in rats. Physical dependence and WS were found to develop against the background of restricted responsiveness of the adrenergic and dopaminergic systems. At the same time, the activity of the serotonin-, GABA-, vasopressin-, and oxytocinergic systems is suppressed at the WS. Agonists of opiate receptors, butorphanol and loperamid, were shown to improve the physical state of the animals with a WS. Similar action was found to be exerted by activators of the adrenergic system (ephedrine, phenylephrine), dopaminergic system (levoDOPA, apomorphine), and serotonergic system (tryptophan), as well as by neuropeptides, vasopressin and oxytocin.", 
        "genre": "article", 
        "id": "sg:pub.10.1007/bf02515049", 
        "inLanguage": "en", 
        "isAccessibleForFree": false, 
        "isPartOf": [
          {
            "id": "sg:journal.1016854", 
            "issn": [
              "0090-2977", 
              "1573-9007"
            ], 
            "name": "Neurophysiology", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "2", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "31"
          }
        ], 
        "keywords": [
          "withdrawal syndrome", 
          "dopaminergic system", 
          "morphine-dependent animals", 
          "neuropeptide mechanisms", 
          "restricted responsiveness", 
          "adrenergic system", 
          "serotonergic system", 
          "opiate receptors", 
          "physical dependence", 
          "drug dependence", 
          "oxytocinergic system", 
          "syndrome", 
          "similar actions", 
          "vasopressin", 
          "neurotransmitters", 
          "animals", 
          "loperamid", 
          "butorphanol", 
          "serotonin", 
          "rats", 
          "agonists", 
          "GABA", 
          "oxytocin", 
          "neuropeptides", 
          "receptors", 
          "responsiveness", 
          "mechanism", 
          "activator", 
          "development", 
          "activity", 
          "action", 
          "background", 
          "time", 
          "system", 
          "same time", 
          "physical state", 
          "state", 
          "dependence", 
          "morphine drug dependence"
        ], 
        "name": "Neurotransmitter and neuropeptide mechanisms responsible for the development of a withdrawal syndrome in morphine-dependent animals", 
        "pagination": "115-120", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1008621160"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1007/bf02515049"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1007/bf02515049", 
          "https://app.dimensions.ai/details/publication/pub.1008621160"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2021-12-01T19:13", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20211201/entities/gbq_results/article/article_335.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1007/bf02515049"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/bf02515049'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/bf02515049'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/bf02515049'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/bf02515049'


     

    This table displays all metadata directly associated to this object as RDF triples.

    108 TRIPLES      22 PREDICATES      66 URIs      57 LITERALS      6 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1007/bf02515049 schema:about anzsrc-for:11
    2 anzsrc-for:1115
    3 schema:author N1e473992a16b44b18d0235656d2ddeb0
    4 schema:citation sg:pub.10.1007/bf02496848
    5 schema:datePublished 1999-03
    6 schema:datePublishedReg 1999-03-01
    7 schema:description The neurotransmitter and neuropeptide mechanisms responsible for the development of the morphine drug dependence and a withdrawal syndrome (WS) were studied in rats. Physical dependence and WS were found to develop against the background of restricted responsiveness of the adrenergic and dopaminergic systems. At the same time, the activity of the serotonin-, GABA-, vasopressin-, and oxytocinergic systems is suppressed at the WS. Agonists of opiate receptors, butorphanol and loperamid, were shown to improve the physical state of the animals with a WS. Similar action was found to be exerted by activators of the adrenergic system (ephedrine, phenylephrine), dopaminergic system (levoDOPA, apomorphine), and serotonergic system (tryptophan), as well as by neuropeptides, vasopressin and oxytocin.
    8 schema:genre article
    9 schema:inLanguage en
    10 schema:isAccessibleForFree false
    11 schema:isPartOf N4aceb7c1472646f69ca5e475e73b6ed2
    12 Nf6b5ebcd34564255a1c00ddaff61843d
    13 sg:journal.1016854
    14 schema:keywords GABA
    15 action
    16 activator
    17 activity
    18 adrenergic system
    19 agonists
    20 animals
    21 background
    22 butorphanol
    23 dependence
    24 development
    25 dopaminergic system
    26 drug dependence
    27 loperamid
    28 mechanism
    29 morphine drug dependence
    30 morphine-dependent animals
    31 neuropeptide mechanisms
    32 neuropeptides
    33 neurotransmitters
    34 opiate receptors
    35 oxytocin
    36 oxytocinergic system
    37 physical dependence
    38 physical state
    39 rats
    40 receptors
    41 responsiveness
    42 restricted responsiveness
    43 same time
    44 serotonergic system
    45 serotonin
    46 similar actions
    47 state
    48 syndrome
    49 system
    50 time
    51 vasopressin
    52 withdrawal syndrome
    53 schema:name Neurotransmitter and neuropeptide mechanisms responsible for the development of a withdrawal syndrome in morphine-dependent animals
    54 schema:pagination 115-120
    55 schema:productId N63c0755ab0ee4a708e46172c559944d4
    56 Nc537fae9101e4b84a486a52e888daec3
    57 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008621160
    58 https://doi.org/10.1007/bf02515049
    59 schema:sdDatePublished 2021-12-01T19:13
    60 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    61 schema:sdPublisher N06118cbfc9da4ef9babcdfc31dce5d73
    62 schema:url https://doi.org/10.1007/bf02515049
    63 sgo:license sg:explorer/license/
    64 sgo:sdDataset articles
    65 rdf:type schema:ScholarlyArticle
    66 N06118cbfc9da4ef9babcdfc31dce5d73 schema:name Springer Nature - SN SciGraph project
    67 rdf:type schema:Organization
    68 N1e473992a16b44b18d0235656d2ddeb0 rdf:first sg:person.01101343454.71
    69 rdf:rest N34951c06b536499a9191a927e617293c
    70 N34951c06b536499a9191a927e617293c rdf:first sg:person.01005415734.94
    71 rdf:rest rdf:nil
    72 N4aceb7c1472646f69ca5e475e73b6ed2 schema:issueNumber 2
    73 rdf:type schema:PublicationIssue
    74 N63c0755ab0ee4a708e46172c559944d4 schema:name doi
    75 schema:value 10.1007/bf02515049
    76 rdf:type schema:PropertyValue
    77 Nc537fae9101e4b84a486a52e888daec3 schema:name dimensions_id
    78 schema:value pub.1008621160
    79 rdf:type schema:PropertyValue
    80 Nf6b5ebcd34564255a1c00ddaff61843d schema:volumeNumber 31
    81 rdf:type schema:PublicationVolume
    82 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    83 schema:name Medical and Health Sciences
    84 rdf:type schema:DefinedTerm
    85 anzsrc-for:1115 schema:inDefinedTermSet anzsrc-for:
    86 schema:name Pharmacology and Pharmaceutical Sciences
    87 rdf:type schema:DefinedTerm
    88 sg:journal.1016854 schema:issn 0090-2977
    89 1573-9007
    90 schema:name Neurophysiology
    91 schema:publisher Springer Nature
    92 rdf:type schema:Periodical
    93 sg:person.01005415734.94 schema:affiliation grid-institutes:grid.419973.1
    94 schema:familyName Filonenko
    95 schema:givenName M. A.
    96 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01005415734.94
    97 rdf:type schema:Person
    98 sg:person.01101343454.71 schema:affiliation grid-institutes:grid.419973.1
    99 schema:familyName Gromov
    100 schema:givenName L. A.
    101 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01101343454.71
    102 rdf:type schema:Person
    103 sg:pub.10.1007/bf02496848 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003276335
    104 https://doi.org/10.1007/bf02496848
    105 rdf:type schema:CreativeWork
    106 grid-institutes:grid.419973.1 schema:alternateName Institute of Pharmacology and Toxicology, Academy of Medical Sciences of Ukraine, Kyiv, Ukraine
    107 schema:name Institute of Pharmacology and Toxicology, Academy of Medical Sciences of Ukraine, Kyiv, Ukraine
    108 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...